IL236070A0 - The intraxten-hgh protein and its use in the treatment of growth hormone deficiency - Google Patents
The intraxten-hgh protein and its use in the treatment of growth hormone deficiencyInfo
- Publication number
- IL236070A0 IL236070A0 IL236070A IL23607014A IL236070A0 IL 236070 A0 IL236070 A0 IL 236070A0 IL 236070 A IL236070 A IL 236070A IL 23607014 A IL23607014 A IL 23607014A IL 236070 A0 IL236070 A0 IL 236070A0
- Authority
- IL
- Israel
- Prior art keywords
- hgh
- treatment
- fusion protein
- growth hormone
- hormone deficiency
- Prior art date
Links
- 206010056438 Growth hormone deficiency Diseases 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261689390P | 2012-06-05 | 2012-06-05 | |
| US201261663475P | 2012-06-22 | 2012-06-22 | |
| US201361763753P | 2013-02-12 | 2013-02-12 | |
| PCT/US2013/031673 WO2013184216A1 (en) | 2012-06-05 | 2013-03-14 | Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL236070A0 true IL236070A0 (en) | 2015-01-29 |
Family
ID=47998551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL236070A IL236070A0 (en) | 2012-06-05 | 2014-12-04 | The intraxten-hgh protein and its use in the treatment of growth hormone deficiency |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20140162949A1 (OSRAM) |
| EP (1) | EP2858664B1 (OSRAM) |
| JP (2) | JP2015520188A (OSRAM) |
| KR (1) | KR20150021072A (OSRAM) |
| CN (2) | CN107320719A (OSRAM) |
| AU (1) | AU2013272220A1 (OSRAM) |
| BR (1) | BR112014030404A2 (OSRAM) |
| CA (1) | CA2875827A1 (OSRAM) |
| DK (1) | DK2858664T3 (OSRAM) |
| ES (1) | ES2733220T3 (OSRAM) |
| HK (1) | HK1208629A1 (OSRAM) |
| IL (1) | IL236070A0 (OSRAM) |
| MX (1) | MX2014014927A (OSRAM) |
| NZ (1) | NZ702557A (OSRAM) |
| PH (1) | PH12014502738A1 (OSRAM) |
| SG (1) | SG11201408152VA (OSRAM) |
| WO (1) | WO2013184216A1 (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7855279B2 (en) | 2005-09-27 | 2010-12-21 | Amunix Operating, Inc. | Unstructured recombinant polymers and uses thereof |
| EP3178835B1 (en) | 2009-02-03 | 2019-04-10 | Amunix Pharmaceuticals, Inc. | Extended recombinant polypeptides and compositions comprising same |
| US9849188B2 (en) | 2009-06-08 | 2017-12-26 | Amunix Operating Inc. | Growth hormone polypeptides and methods of making and using same |
| US20160158321A1 (en) * | 2013-03-11 | 2016-06-09 | Amunix Operting Inc. | Treatment of pediatric growth hormone deficiency with human growth hormone analogues |
| IL319047A (en) | 2015-08-28 | 2025-04-01 | Amunix Operating Inc | Chimeric polypeptide composition and methods for its preparation and use |
| WO2017136583A1 (en) | 2016-02-02 | 2017-08-10 | Versartis, Inc. | Growth hormone treatment adherence system |
| JP6896749B2 (ja) * | 2016-02-17 | 2021-06-30 | ジェネクシン・インコーポレイテッドＧｅｎｅｘｉｎｅ， Ｉｎｃ． | 組換えｈＧＨを含む、成長ホルモン欠乏を治療するための薬学組成物 |
| WO2017142331A1 (en) * | 2016-02-17 | 2017-08-24 | Genexine, Inc. | Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency |
| US20200000884A1 (en) * | 2016-07-27 | 2020-01-02 | Amunix Pharmaceuticals, Inc. | Treatment of adult growth hormone deficiency with human growth hormone analogues |
| JOP20190019A1 (ar) | 2016-08-30 | 2019-02-12 | Genexine Inc | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| AU2018393111B2 (en) | 2017-12-21 | 2025-07-10 | Amunix Pharmaceuticals, Inc. | Release segments and binding compositions comprising same |
| CA3100035A1 (en) | 2018-08-27 | 2020-03-05 | Regeneron Pharmaceuticals, Inc. | Use of raman spectroscopy in downstream purification |
| WO2021136223A1 (en) | 2019-12-31 | 2021-07-08 | Beijing Ql Biopharmaceutical Co., Ltd. | Fusion proteins of glp-1 and gdf15 and conjugates thereof |
| CN113728013B (zh) | 2020-01-11 | 2022-06-14 | 北京质肽生物医药科技有限公司 | Glp-1和fgf21的融合蛋白的缀合物 |
| KR20230083294A (ko) | 2020-09-30 | 2023-06-09 | 베이징 큐엘 바이오파마슈티컬 컴퍼니 리미티드 | 폴리펩타이드 접합체 및 사용 방법 |
| CN116554343B (zh) * | 2022-01-30 | 2024-07-12 | 领诺(上海)医药科技有限公司 | 一种长效重组人生长激素及其应用 |
| CA3252113A1 (en) | 2022-03-30 | 2023-10-05 | Beijing Ql Biopharmaceutical Co., Ltd. | Liquid pharmaceutical compositions of polypeptide conjugates and their methods of use |
| CN116003632A (zh) * | 2022-12-07 | 2023-04-25 | 北京大学 | 长效缓释型人重组生长激素融合蛋白及其药物组合物和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898830A (en) | 1979-07-05 | 1990-02-06 | Genentech, Inc. | Human growth hormone DNA |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| EP0983303B1 (en) | 1997-05-21 | 2006-03-08 | Biovation Limited | Method for the production of non-immunogenic proteins |
| US6406632B1 (en) | 1998-04-03 | 2002-06-18 | Symyx Technologies, Inc. | Rapid characterization of polymers |
| GB9815157D0 (en) | 1998-07-13 | 1998-09-09 | Metron Designs Ltd | High resolution pulse width setting from relatively low frequency clocks |
| US20030228309A1 (en) | 2000-11-08 | 2003-12-11 | Theodora Salcedo | Antibodies that immunospecifically bind to TRAIL receptors |
| WO2002079415A2 (en) | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
| US7294513B2 (en) | 2002-07-24 | 2007-11-13 | Wyatt Technology Corporation | Method and apparatus for characterizing solutions of small particles |
| EP3178835B1 (en) * | 2009-02-03 | 2019-04-10 | Amunix Pharmaceuticals, Inc. | Extended recombinant polypeptides and compositions comprising same |
| US8703717B2 (en) * | 2009-02-03 | 2014-04-22 | Amunix Operating Inc. | Growth hormone polypeptides and methods of making and using same |
| US8680050B2 (en) * | 2009-02-03 | 2014-03-25 | Amunix Operating Inc. | Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same |
| CA2764105A1 (en) | 2009-06-08 | 2010-12-16 | Amunix Operating Inc. | Growth hormone polypeptides and methods of making and using same |
-
2013
- 2013-03-14 BR BR112014030404A patent/BR112014030404A2/pt not_active IP Right Cessation
- 2013-03-14 EP EP13712656.1A patent/EP2858664B1/en active Active
- 2013-03-14 MX MX2014014927A patent/MX2014014927A/es unknown
- 2013-03-14 JP JP2015516010A patent/JP2015520188A/ja active Pending
- 2013-03-14 SG SG11201408152VA patent/SG11201408152VA/en unknown
- 2013-03-14 NZ NZ702557A patent/NZ702557A/en not_active IP Right Cessation
- 2013-03-14 US US13/829,369 patent/US20140162949A1/en not_active Abandoned
- 2013-03-14 KR KR20147036167A patent/KR20150021072A/ko not_active Withdrawn
- 2013-03-14 AU AU2013272220A patent/AU2013272220A1/en not_active Abandoned
- 2013-03-14 ES ES13712656T patent/ES2733220T3/es active Active
- 2013-03-14 DK DK13712656.1T patent/DK2858664T3/da active
- 2013-03-14 HK HK15109368.8A patent/HK1208629A1/xx unknown
- 2013-03-14 CN CN201710596161.5A patent/CN107320719A/zh not_active Withdrawn
- 2013-03-14 CN CN201380041556.9A patent/CN104519903A/zh active Pending
- 2013-03-14 WO PCT/US2013/031673 patent/WO2013184216A1/en not_active Ceased
- 2013-03-14 CA CA2875827A patent/CA2875827A1/en not_active Abandoned
-
2014
- 2014-12-04 IL IL236070A patent/IL236070A0/en unknown
- 2014-12-05 PH PH12014502738A patent/PH12014502738A1/en unknown
-
2017
- 2017-03-08 JP JP2017043512A patent/JP2017125051A/ja active Pending
- 2017-07-13 US US15/648,967 patent/US20180051063A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PH12014502738A1 (en) | 2015-02-02 |
| MX2014014927A (es) | 2015-05-15 |
| CN104519903A (zh) | 2015-04-15 |
| JP2015520188A (ja) | 2015-07-16 |
| SG11201408152VA (en) | 2015-01-29 |
| CN107320719A (zh) | 2017-11-07 |
| JP2017125051A (ja) | 2017-07-20 |
| US20140162949A1 (en) | 2014-06-12 |
| NZ702557A (en) | 2017-06-30 |
| HK1208629A1 (en) | 2016-03-11 |
| AU2013272220A1 (en) | 2015-01-15 |
| CA2875827A1 (en) | 2013-12-12 |
| KR20150021072A (ko) | 2015-02-27 |
| BR112014030404A2 (pt) | 2017-06-27 |
| EP2858664A1 (en) | 2015-04-15 |
| US20180051063A1 (en) | 2018-02-22 |
| ES2733220T3 (es) | 2019-11-28 |
| EP2858664B1 (en) | 2019-05-08 |
| WO2013184216A1 (en) | 2013-12-12 |
| DK2858664T3 (da) | 2019-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL236070A0 (en) | The intraxten-hgh protein and its use in the treatment of growth hormone deficiency | |
| IL228813B (en) | A polypeptide containing a first and second immunoglobulin each containing a single variable site and its use in the treatment of diseases | |
| IL242610A0 (en) | History of pyrazolopyrrolidine and their use in the treatment of diseases | |
| PL2970398T3 (pl) | Białka f rsv przed fuzją i ich zastosowanie | |
| PL3310805T3 (pl) | Białka fuzyjne pd-1-cd28 i ich zastosowanie w medycynie | |
| IL222382A0 (en) | Robo1-fc fusion protein and use thereof for treating tumours | |
| IL279676A (en) | Recombinant proteins and therapeutic uses | |
| HUE068364T2 (hu) | Faktor 1 fehérje betegségek kézélésében vagy megelõzésében váló alkalmazásra | |
| EP3029072A4 (en) | Glp-1 analog fusion protein and preparation method and use thereof | |
| PL3004112T3 (pl) | Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby | |
| ZA201305266B (en) | Robo1-fc fusion protein for use in the treatment of hepatocarcinoma | |
| PL2668205T3 (pl) | Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie | |
| GB201222455D0 (en) | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease | |
| EP2896294A4 (en) | MICRORNA IN HUMAN MILK AND USE THEREOF | |
| IL238897A0 (en) | Growth hormone-albumin fusion proteins, their formulation and use | |
| ZA201401800B (en) | Novel plant defensins and use in the treatment of proliferative diseases | |
| ZA201503747B (en) | Protein slurp-1 for use in the treatment of ocular diseases | |
| EP3085710A4 (en) | Protein and use thereof in treating multiple sclerosis | |
| EP2934699A4 (en) | PLOD2 GENE STIMULATORS AND USE OF SAID STIMULATORS FOR TREATING SKIN | |
| GB201117876D0 (en) | Peptides and their use in treatment | |
| GB201015789D0 (en) | Peptides and their use in the treatment | |
| PT2821083T (pt) | Utilização combinada de amidas de ácidos mono e dicarboxílicos e silimarina no tratamento de doenças renais | |
| HK1186191A (en) | Robo1-fc fusion protein for use in the treatment of hepatocarcinoma | |
| GB201210664D0 (en) | Means and methods for the reduction of photorespiration in crops | |
| AP2015008849A0 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease |